Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - sugammadex - solution for injection - sugammadex 100 mg/ml - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

n.v. organon - sugammadex (sugammadex sodium) - solution for i/v injection - 100mg/ml

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - sugammadex sodium (unii: erj6x2mxv7) (sugammadex - unii:361lpm2t56) - bridion ® is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery. bridion is contraindicated in patients with known hypersensitivity to sugammadex or any of its components. hypersensitivity reactions that occurred varied from isolated skin reactions to serious systemic reactions (i.e., anaphylaxis, anaphylactic shock) and have occurred in patients with no prior exposure to sugammadex [see warnings and precautions (5.1), adverse reactions (6)] . risk summary there are no data on bridion use in pregnant women to inform any drug-associated risks. in animal reproduction studies, there was no evidence of teratogenicity following daily intravenous administration of sugammadex to rats and rabbits during organogenesis at exposures of up to 6 and 8 times, respectively, the maximum recommended human dose (mrhd) of 16 mg/kg. however, there was an increase in the incide

Malta - English - Medicines Authority

pharmazac, s.a. 31 naousis str., 104 47, athens,, greece - sugammadex - solution for injection - sugammadex 200 mg - all other therapeutic products

Malta - English - Medicines Authority

pharmazac, s.a. 31 naousis str., 104 47, athens,, greece - sugammadex - solution for injection - sugammadex 500 mg - all other therapeutic products

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - sugammadex -

United States - English - NLM (National Library of Medicine)

oryza pharmaceuticals inc. - papaverine hydrochloride (unii: 23473ec6bq) (papaverine - unii:daa13nkg2q) - papaverine is recommended in various conditions accompanied by spasm of smooth muscle, such as vascular spasm associated with acute myocardial infarction (coronary occlusion), angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease in which there is a vasospastic element, or certain cerebral angiospastic states; and visceral spasm, as in ureteral, biliary, or gastrointestinal colic. intravenous injection of papaverine is contraindicated in the presence of complete atrioventricular heart block. when conduction is depressed, the drug may produce transient ectopic rhythms of ventricular origin, either premature beats or paroxysmal tachycardia. papaverine hydrochloride is not indicated for the treatment of impotence by intracorporeal injection. the intracorporeal injection of papaverine hydrochloride has been reported to have resulted in persistent priapism requiring medical and surgical intervention. drug dependence resulting from the abuse of many of the selective depressants, includin

Malta - English - Medicines Authority

genthon bv microweg 22, 6545 cm nijmegen, netherlands - sugammadex - solution for injection - sugammadex 100 mg/ml - all other therapeutic products

Malta - English - Medicines Authority

genthon bv microweg 22, 6545 cm nijmegen, netherlands - sugammadex - solution for injection - sugammadex 100 mg/ml - all other therapeutic products

Malta - English - Medicines Authority

synthon bv microweg 22, 6545 cm nijmegen, netherlands - sugammadex - solution for injection - sugammadex 100 mg/ml - all other therapeutic products